Peter T. Slover
Chief Financial OfficerMr. Peter T. Slover, CPA, also known as Pete, has been the Chief Financial Officer of Contineum Therapeutics, Inc. (formerly known as Pipeline Therapeutics, Inc.) since September 2020. He had been the Chief Financial Officer of Sophiris Bio, Inc. since January 10, 2013. Mr. Slover served as the Head of Finance and Principal Accounting Officer at Sophiris Bio, Inc. from April 4, 2012 to January 2013. He joined Sophiris in April 2011. He served as the Principal Financial Officer, Principal Accounting Officer and Vice President of Finance and Operations at Anadys Pharmaceuticals Inc. since September 2009. Mr. Slover served as Senior Director of Finance and Controller of Anadys Pharmaceuticals Inc. from January 2009 to September 2009. He joined Anadys Pharmaceuticals Inc. in April 2004. He served as Anadys Pharmaceuticals Inc.'s Manager of Financial Reporting from April 2004 to December 2005, as its Senior Manager, Financial Reporting & Internal Controls from January 2006 to July 2006, as its Associate Controller from August 2006 to December 2006 and as its Controller from January 2007 to December 2008. Prior to joining Anadys Pharmaceuticals Inc., he began his career as an auditor at KPMG LLP where he spent seven years in public accounting. He is a licensed Certified Public Accountant in the State of California. Mr. Slover holds a BS degree in Business Administration from Shippensburg University.
Positions
- Company NameContineum Therapeutics, Inc.Stock CodeCTNMPositionChief Financial OfficerColleagues
- CNCarmine N. StengonePresident, CEO & Director
- EBEvert B. SchimmelpenninkIndependent Chairman of the Board
- TRTimothy R. WatkinsChief Medical Officer & Head of Development
- MPMorgan PaulsenSenior Manager of Accounting
- DSDaniel S. LorrainChief Science Officer
- TRTodd R. BradyIndependent Director
- TATroy A. IgnelziIndependent Director
- SBSarah BoyceIndependent Director
